Charles Y. Lin
Chief Scientific Officer · Kronos Bio, Inc.
Individual
- 2024
- Oct 15, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Charles Y. Lin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
- BX Mozart ML-2 Holdco L.P. - $2.35B in MDLN purchases and sales in the last 12 months
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- LILLY ENDOWMENT INC - $2.23B in LLY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles Y. Lin?
Charles Y. Lin is a corporate insider, tracked as Chief Scientific Officer of Kronos Bio, Inc. (KRON). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Charles Y. Lin last file a Form 4?
The only primary Form 4 on record is dated 15 October 2024.